Sandoz Group AG is a Switzerland based company which is active in healthcare technology industry. The Company operates in two businesses, Generics and Biosimilars. Generics business develops, manufacture and market active ingredients and finished dosage forms of small molecule pharmaceuticals, finished dosage forms of anti-infectives and active pharmaceutical ingredients and intermediates. Biosimilars business develops, manufacture and market protein-based and other biological products which are similar to another already approved biological medicines. Company’s product portfolio comprising Generics and Biosimilars covers all therapeutic areas for patient treatment such as cardiovascular, central nervous system, oncology, anti-infectives, pain and respiratory. The Company serves customers worldwide.
Company Information
About this company
Key people
Richard Saynor
Chief Executive Officer
Remco Steenbergen
Chief Financial Officer
Christophe Delenta
President, Europe
Keren Haruvi
President, North America
Peter Stenico
President, International
Claire D'Abreu-Hayling
Chief Scientific Officer
Ingrid Sollerer
Chief Compliance Officer, Group General Counsel
Glenn A. Gerecke
Chief Manufacturing and Supply Officer
Rebecca Guntern
Chief Commercial Officer
Tripti Jha
Chief People Officer
Gilbert Ghostine
Non-Executive Independent Chairman of the Board
Karen J. Huebscher
Non-Executive Independent Vice Chairman of the Board
Shamiram R. Feinglass
Non-Executive Independent Director
Mathai Mammen
Non-Executive Independent Director
Graeme David Pitkethly
Non-Executive Independent Director
Click to see more
Key facts
- Shares in issue440.00m
- EPICSDZ
- ISINCH1243598427
- LocationSwitzerland
- SectorHealthcare
- IndustryBiotechnology & Drugs
- Market capCHF 26.18bn
- Employees23,406
- ExchangeSIX Swiss Exchange
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.